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Abstract
Background: In maternal medicine, research evidence is scattered making it difficult to access
information for clinical decision making. Systematic reviews of good methodological quality are
essential to provide valid inferences and to produce usable evidence summaries to guide
management. This review assesses the methodological features of existing systematic reviews in
maternal medicine, comparing Cochrane and non-Cochrane reviews in maternal medicine.
Methods: Medline, Embase, Database of Reviews of Effectiveness (DARE) and Cochrane Database
of Systematic Reviews (CDSR) were searched for relevant reviews published between 2001 and
2006. We selected those reviews in which a minimum of two databases were searched and the
primary outcome was related to the maternal condition. The selected reviews were assessed for
information on framing of question, literature search and methods of review.
Results: Out of 2846 citations, 68 reviews were selected. Among these, 39 (57%) were Cochrane
reviews. Most of the reviews (50/68, 74%) evaluated therapeutic interventions. Overall, 54/68
(79%) addressed a focussed question. Although 64/68 (94%) reviews had a detailed search
description, only 17/68 (25%) searched without language restriction. 32/68 (47%) attempted to
include unpublished data and 11/68 (16%) assessed for the risk of missing studies quantitatively. The
reviews had deficiencies in the assessment of validity of studies and exploration for heterogeneity.
When compared to Cochrane reviews, other reviews were significantly inferior in specifying
questions (OR 20.3, 95% CI 1.1–381.3, p = 0.04), framing focussed questions (OR 30.9, 95% CI 3.7-
256.2, p = 0.001), use of unpublished data (OR 5.6, 95% CI 1.9–16.4, p = 0.002), assessment for
heterogeneity (OR 38.1, 95%CI 2.1, 688.2, p = 0.01) and use of meta-analyses (OR 3.7, 95% CI 1.3–
10.8, p = 0.02).
Conclusion: This study identifies areas which have a strong influence on maternal morbidity and
mortality but lack good quality systematic reviews. Overall quality of the existing systematic
reviews was variable. Cochrane reviews were of better quality as compared to other reviews.
There is a need for good quality systematic reviews to inform practice in maternal medicine.
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Background
Maternal medicine has emerged as an increasingly impor-
tant area for the obstetricians dealing with high risk preg-
nancies. It involves care of women with medical
complications of pregnancy which may be specific to or
predate the pregnancy [1]. Approximately half of complex
pregnancies are related to an abnormal fetal or obstetric
factor, whereas medical diseases constitute the remainder
of this high risk obstetric population. Scientific develop-
ments in internal or general medicine have led to newer
diagnostic and therapeutic strategies to manage medical
diseases. The physiological changes during pregnancy can
affect not only the clinical presentation of a medical prob-
lem but may give rise to difficulties in diagnosing and
managing these problems. In order to provide the best
possible quality of care to women with complicated preg-
nancies obstetricians dealing with the high risk obstetric
cases should have evidence based knowledge on the diag-
nostic, therapeutic and prognostic aspects of maternal
medicine.
Recently there has been a proliferation of systematic
reviews as one of the key tools for evidence-based medi-
cine [2]. As maternal medicine covers the issues related to
pregnancy as well as general medicine, research evidence
is scattered in the literature making it difficult to access
information for clinical decision making. Systematic
reviews provide a way forward as individual pieces of
research can be collected within literature reviews and if
appropriate subjected to meta-analysis [3]. Good method-
ological quality is essential for these reviews to have valid
inferences and to produce usable evidence summaries to
guide the obstetric management [4]. This study examines
the methodological features of recently published system-
atic reviews in maternal medicine and specifically com-
pares Cochrane to non-Cochrane reviews.
Methods
To determine the quality of current systematic reviews in
maternal medicine, we developed a priori protocol based
on recommended methods [2,5-7].
A computerised search of publicly available databases was
conducted. Ovid Medline (1996 to date), Embase (1996
to date), Database of Reviews of Effectiveness and
Cochrane Database of Systematic Reviews were searched
for relevant reviews published between 2001 and 2006.
Key word combinations like Pregnan$, Matern$, Gesta-
tion$, Obstetric$, Complication$, Systematic review$ and
Meta analys$ were used for the search strategy in addition
to word variants, subject headings and free text. The $ sign
is a truncator used to capture any word that begin with the
letters in front of the $ sign in the search terms used. Addi-
tionally common and specific medical problems related
to pregnancy were searched using key words describing
names of the disease such as Pre eclampsia, Hypertension,
Diabetes, Cholestasis, Anaemia, Thrombocytopaenia,
Thrombophilia, and Thromboembolism. Hand search of
reference lists was conducted of all relevant articles to
identify any missing reviews. The searches were limited to
reviews between 2001 and 2006 due to increasing devel-
opments in the field of maternal medicine in recent years.
Inclusion criteria required a minimum of two publicly
available databases searched for a medical condition spe-
cific to or predating pregnancy and maternal factor as the
primary outcome. We searched without language restric-
tions. All the reviews with fetal or neonatal factor as the
primary outcome were excluded.
Two reviewers independently extracted and assessed the
data according to a checklist formulated as part of our pro-
tocol (Table 1). The methodological quality of each
review was assessed by focussing on framing of the ques-
tion, literature search and review methods scrutinising
methods of literature search and data synthesis. The items
assessed internal validity and explicitness of reporting,
both of which are important issues in quality of reviews.
Differences between reviewers were resolved by discus-
sion. We computed rates of compliance with the items in
our checklist and compared Cochrane and non-Cochrane
reviews. Odds ratios and their 95% confidence intervals
were computed. All statistical analysis was performed
using Stata 8.0 statistical package.
Results
The initial literature search resulted in 2864 citations. Of
these 68 reviews [8-75] fulfilled the inclusion criteria and
were selected for detailed study (Fig 1). A total of 39
(57%) Cochrane reviews [8-46] and 29 (43%) non
Cochrane reviews [47-75] were included. Most of the
reviews assessed therapeutic interventions (50/68, 74%),
and the rest were reviews on prognosis (12/68, 17%) and
diagnosis (6/68, 9%). The range of clinical topics dealt
with by the reviews is shown in Fig 2.
Overall quality of the existing systematic reviews was var-
iable (Fig 3). Majority of the reviews (62/68, 91%) speci-
fied the question and 54/68 (79%) had a focussed
question with clearly defined population and outcome
measures. A large population of the reviews (64/68, 94%)
had a detailed search description including databases
searched and key words used. Almost half of the reviews
(32/68, 47%) attempted to include unpublished data.
However only 11/68 (16%) assessed the risk of missing
studies quantitatively and 17/68 (25%) searched without
language restriction. Almost all the reviews had good tab-
ulation of results and characteristics of included studies
(65/68, 96%).BMC Medicine 2007, 5:10 http://www.biomedcentral.com/1741-7015/5/10
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The quality of Cochrane and non Cochrane reviews is
given in Fig 3. Cochrane reviews [8-46] had specified the
questions more often than non Cochrane reviews [47-
51,53-55,58-60,62-71,73-75] (OR 20.3, 95% CI 1.1–
381.3, p = 0.04) and were also framed narrowly focussed
questions specifying the population, interventions and
comparisons, outcome of the study and the study design
(OR 30.9, 95% CI 3.7- 256.2, p = 0.001). Cochrane
reviews attempted more often to include unpublished
data in literature search (OR 5.6, 95% CI 1.9–16.4, p =
0.002). Twelve out of 29 non-Cochrane reviews
[48,50,53-55,64-66,68-71] performed a meta-analysis,
but there was good awareness of where this technique was
valuable and where it was not applicable. Meta analysis
technique (OR 3.7, 95% CI 1.3–10.8, p = 0.02) and
assessment for heterogeneity (OR 38.1, 95%CI 2.1, 688.2,
p = 0.01) was found to be employed significantly more
often by Cochrane reviews.
Discussion
Our study showed that the Cochrane reviews [8-46] were
of consistently high methodological quality and had a
greater level of assessment for quality of included studies.
They always did a meta-analysis [9,12,17,19-25,27-40,44-
46] where applicable. This is reassuring for clinicians who
rely on them for decision-making. It is possible that the
Clinical topics covered by existing maternal medicine reviews Figure 2
Clinical topics covered by existing maternal medicine 
reviews.
Review Topics in Maternal Medicine
Hepatic disease
(n=1, 1%) Hypertensive disorders
(n=23, 35%)
Thromboembolic disease
(n=7, 10%)
Infective disorders
(n=6, 9%)
Psychiatric disorders
(n=13, 20%)
Urinary tract disorders
(n=2, 3%)
Haematological disease
(n=2, 3%)
Neurology
(n=1, 1%)
Endocrine disorders
(n=4, 6%)
Respiratory disease
(n=3, 4%)
Musculoskeletal
(n=2,3%)
Gastrointestinal tract disorders
(n=3, 4%)
Drugs
(n=1, 1%)
Total number of reviews=68
Table 1: Checklist used to assess the quality of systematic 
reviews included in the review.
Title
Reference
First Author
Year of publication
Journal
Publication dates of literature included
No. studies included in the review
No. of reviewers
Type of review therapeutic/
prognostic/diagnostic
Framing of question:
Question specified yes/no
Question relevant yes/no
Narrow focus of question yes/no
Explicit testable hypothesis yes/no
Literature search
Adequate search description (incl. names of 
databases and search terms)
yes/no
Use of reference list yes/no
Search without language restriction yes/no
Assessment for risk of missing studies yes/no
Inclusion of unpublished data yes/no
Quality assessment of included studies:
Potential sources of bias (ie. randomisation) yes/no
Data collection (prospective/retrospective) yes/no
Follow-up yes/no
Blinding of assessors* yes/no
Description of intervention* yes/no
*applicable only to interventional reviews
Search strategy and study selection process for review of the  methodological features of systematic reviews in maternal  medicine Figure 1
Search strategy and study selection process for review of the 
methodological features of systematic reviews in maternal 
medicine.
SEARCH STRATEGY
Electronic literature search in Medline,Embase, Cochrane and DARE combining terms (Pregnan$, matern$,
gestation$ OR Obstetrics) AND (medicine OR complication OR medic$) AND (systematic review$ OR meta-
analysis)
Citations excluded because they
did not meet selection
criteria
n=2643
Studies excluded due to duplication,
non-systematic approach
(eg. clinical update), inappropriate
outcomes (eg. fetal), or inadequate
search strategy
n=135
Diagnostic reviews 
n=6
Prognostic reviews
n=12
Therapeutic reviews
n=50
Studies included in
Systematic review
n=68
Citations retrieved for more
detailed evaluation of full manuscripts
n=203
Total citations
screened for relevance
n=2846BMC Medicine 2007, 5:10 http://www.biomedcentral.com/1741-7015/5/10
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restriction on the length of published non Cochrane
reviews by journals could have influenced their quality
scores. However this issue has been addressed by increase
in the web publishing of additional material in the elec-
tronic format by many journals in recent years.
This work has highlighted that literature searches in
reviews are currently generally poor. A search that is not
thorough risks giving biased inferences. We identified
considerable room for improvement in certain methodo-
logical features of non Cochrane reviews. However all the
selected reviews were similar in searches without language
restriction and assessment for risk of missing studies.
Interestingly use of reference list of the selected papers to
identify any other eligible studies for inclusion in the
review was found to be more frequent in non Cochrane
reviews (OR 0.2, 95% CI 0.1–0.7, p < 0.007). This could
be a result of the generic search strategy employed by
Cochrane reviews with unclear mention of the use of ref-
erence lists in individual reviews. Cochrane reviews were
found more likely to attempt to include unpublished data
compared to non Cochrane reviews (OR 5.6, 95% CI 1.9–
16.4, p < 0.002). This attempt to avoid publication bias is
significant as the odds of publication are higher if the
results are found to be significant compared to studies
with non-significant results.[76]
This study identified areas of maternal medicine that lack
good quality systematic reviews. Majority of the reviews
were on hypertensive disorders [8,10,11,17,19-23,31-
34,37,48,53,55,58,64,65,69,70], psychiatry
[15,27,43,47,50-52,56,57,59,61,74,75], or thromboem-
bolism [26,42,62-66,68]. Even among these commonly
addressed areas, a very narrow spectrum of diseases was
covered. For example reviews in psychiatry were solely
focussed on depression during pregnancy and reviews in
hypertension focussed mainly on pre eclampsia. Reviews
for some very common medical problems during preg-
Quality of Cochrane and non Cochrane systematic reviews included in the study Figure 3
Quality of Cochrane and non Cochrane systematic reviews included in the study.
Framing of question
Question specified
Narrow focus of question
Explicit testable hypothesis
Adequate search description
Use of reference list
Search without language restriction
Attempt to include unpublished data
Potential sources of bias
Data collection
Follow-up
Blinding of assessors
Description of intervention
Tabulation of results
Meta-analysis
Assessment for heterogeneity
Literature search
Methods of review
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39
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25
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17 22
38 1
24
32
35
14
8
7
2
9
38 1
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23
16
7
26
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10
7
7
23
19
8
11
13
27
12
17
6
13
22
3
8
19
22
22
6
10
18
7
3
2
16
12
Assessment for risk of missing
studies
Odds ratio
(95% CI)
20.3 (1.1 - 381.3)
30.9 (3.7 - 256.2)
2.49 (0.8 - 7.0)
4.39 (0.4 - 44.5)
0.2 (0.1 - 0.7)
0.4 (0.1 - 1.3)
0.4 (0.1 - 1.4)
20.3 (1.1 - 381.3)
5.6 (1.9 - 16.4)
2.0 (0.7 - 6.1)
10.3 (3.2 - 33.0)
11.5 (2.1 -63.4)
17.5 (0.8 - 373.8)
5.2 (0.2 - 119.7)
3.7 (1.3 - 10.8)
38.1 (2.1 - 688.2)
0.04
0.001
0.1
0.2
0.007
0.1
0.1
0.04
0.002
0.2
0.000
0.005
0.07
0.3
0.02
0.01
P value Cochrane reviews (n=39) Other reviews (n=29)
Yes/Adequate No/Inadequate/Not reportedBMC Medicine 2007, 5:10 http://www.biomedcentral.com/1741-7015/5/10
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nancy were missing or of poor quality. We found very few
reviews on diabetes mellitus [12,39,49,73] and chronic
hypertension and none on thyroid disorders.
With advancement in neonatology and paediatric medi-
cine, more and more women with congenital problems
such as congenital heart disease and inherited metabolic
diseases are reaching child bearing age and considering
pregnancy. There is an urgent need to have some cumula-
tive evidence on management of this high risk group in
the best possible way.
This study has some potential limitations. With our strict
criteria to include reviews conducted with two publicly
available databases, it is possible that some of the good
quality reviews in maternal medicine using single data-
base are missed. Another limitation relates to maternal
outcome as the main focus of our study. We excluded all
those reviews in which association between maternal dis-
ease and perinatal outcome was assessed. Keeping in
mind the primary goal of an obstetrician being directed
towards achieving a healthy and safe outcome for both
mother and fetus, good quality evidenced based informa-
tion on medical problems during pregnancy can only be
achieved by reviewing methodological features of all
aspects of maternal medicine irrespective of the endpoint.
Due to the absence of blinding of the reviewers to the
source of the review it is difficult to completely rule out
any resultant bias.
Conclusion
Evidence based healthcare continues to make important
contributions to the well being of pregnant women. This
study has identified areas in maternal medicine that lack
good quality systematic reviews. Overall quality of the
existing systematic reviews was variable, with Cochrane
reviews better than other reviews. To achieve better under-
standing and provide high quality obstetric care for preg-
nant women with medical problems, it is important to
ensure that systematic reviews in maternal medicine are
conducted to cover wider spectrum of diseases, and are
reported at the highest possible quality.
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